References
- Anzalone, A. V., P. B. Randolph, J. R. Davis, A. A. Sousa, L. W. Koblan, J. M. Levy, P. J. Chen, C. Wilson, A. Newby, A. Raguram, et al. 2019. “Search-and-Replace Genome Editing without Double-Strand Breaks or Donor DNA.” Nature 576 (7785): 149–157. doi:https://doi.org/10.1038/s41586-019-1711-4.
- Beckman, E. S., N. Deuitch, M. Michie, M. A. Allyse, K. A. Riggan, and K. E. Ormond. 2019. “Attitudes toward Hypothetical Uses of Gene-Editing Technologies in Parents of People with Autosomal Aneuploidies.” CRISPR Journal 2 (5): 324–330. doi:https://doi.org/10.1089/crispr.2019.0021.
- Chan, S. 2020. “Playing It Safe? Precaution, Risk, and Responsibility in Human Genome Editing.” Perspectives in Biology and Medicine 63 (1): 111–125. doi:https://doi.org/10.1353/pbm.2020.0009.
- Coutifaris, C. 2019. “Elective Frozen Embryo Transfer for All?” Lancet 393 (10178): 1264–1265. doi:https://doi.org/10.1016/S0140-6736(19)30426-X.
- Emanuel, E. J., D. Wendler, and C. Grady. 2000. “What Makes Clinical Research Ethical?” JAMA 283 (20): 2701–2711. doi:https://doi.org/10.1001/jama.283.20.2701.
- European Society of Human Reproduction and Embryology. 2017. ESHRE Annual Report. Belgium: European Society of Human Reproduction and Embryology.
- Eyal, N., J. Kimmelman, L. G. Holtzman, and M. Lipsitch. 2019. “REgulating Impact on Bystandinder in Clinical Trials: An Unsettled Frontier.” Clinical Trials 16 (5, October): 450–454. doi:https://doi.org/10.1177/1740774519862783.
- Farrell, R. M., M. Michie, C. T. Scott, R. Flyckt, and M. LaPlante. 2019. “Prioritizing Women’s Health in Germline Editing Research.” AMA Journal of Ethics 21: E1071–E1078.
- Han, H. A., J. K. S. Pang, and B. S. Soh. 2020. “Mitigating Off-target Effects in CRISPR/Cas9-Mediated in Vivo Gene Editing.” Journal of Molecular Medicine 98 (5): 615–632. doi:https://doi.org/10.1007/s00109-020-01893-z. March 20.
- Institute of Medicine and National Research Council. 2005. Guidelines for Human Embryonic Stem Cell Research. Washington DC: National Academies Press.
- Kimmelman, J. 2007. “Missing the Forest: Further Thoughts on the Ethics of Bystander Risk in Medical Research.” Cambridge Quarterly of Healthcare Ethics 16 (4): 483–490. doi:https://doi.org/10.1017/S0963180107070648.
- Klipstein, S. 2017. “Parenting in the Age of Preimplantation Gene Editing.” Hastings Center Report 47: S28–S33. doi:https://doi.org/10.1002/hast.792.
- Lander, E. S., F. Baylis, F. Zhang, E. Charpentier, P. Berg, C. Bourgain, B. Friedrich, J. K. Joung, J. Li, D. Liu, et al. 2019. “Adopt a Moratorium on Heritable Genome Editing.” Nature 567 (7747): 165–168. doi:https://doi.org/10.1038/d41586-019-00726-5.
- Lyerly, A. D., M. O. Little, and R. Faden. 2008. “The Second Wave: Toward Responsible Inclusion of Pregnant Women in Research.” IJFAB: International Journal of Feminist Approaches to Bioethics 1 (2): 5–22. doi:https://doi.org/10.3138/ijfab.1.2.5.
- Malek, J. 2007. “Understanding Risks and Benefits in Research on Reproductive Genetic Technologies.” Journal of Medicine and Philosophy 32 (4): 339–358. doi:https://doi.org/10.1080/03605310701515369.
- Malek, J. 2013. “Use or Refuse Reproductive Genetic Technologies: Which Would a “Good Parent” Do?” Bioethics 27 (2): 59–64. doi:https://doi.org/10.1111/j.1467-8519.2011.01890.x.
- Mehravar, M., A. Shirazi, M. Nazari, and M. Banan. 2019. “Mosaicism in CRISPR/Cas9-Mediated Genome Editing.” Developmental Biology 445 (2): 156–162. doi:https://doi.org/10.1016/j.ydbio.2018.10.008.
- National Academics of Sciences, Engineering, and Medicine. 2017. Human Genome Editing: Science, Ethics, and Governance. Washington DC: National Academies Press.
- Nuffield Council on Bioethics. 2018. Genome Editing and Human Reproduction: Social and Ethical Issues. London: Nuffield Council on Bioethics.
- Press, N. A., and C. H. Browner. 1991. “‘Collective Fictions’: Similarities in Reasons for Accepting Maternal Serum Alpha-fetoprotein Screening among Women of Diverse Ethnic and Social Class Backgrounds.” Fetal Diagnosis and Therapy 8 (1): 97–106. doi:https://doi.org/10.1159/000263878.
- Resnik, D. B., and R. Sharp. 2006. “Protecting Third Parties in Human Subjects Research.” IRB 28 (4): 1–7.
- Strong, K. A., C. F. Jordens, I. H. Kerridge, J. M. Little, and R. A. Ankeny. 2011. “It’s Time to Reframe the Savior Sibling Debate.” AJOB Primary Research 2 (3): 13–25. doi:https://doi.org/10.1080/21507716.2011.616184.
- Wee, S. L. 2019. “Chinese Scientist Who Genetically Edited Babies Gets 3 Years in Prison.” New York Times. https://www.nytimes.com/2019/12/30/business/china-scientist-genetic-baby-prison.html
- Weisberg, S. M., D. Badgio, and A. Chatterjee. 2017. “A CRISPR New World: Attitudes in the Public toward Innovations in Human Genetic Modification.” Frontiers in Public Health 5.